An interventional study of Prize Contingency Management for Alcohol Abstinence and Standard Care in Alcohol Use Disorder and Contingency Management, sponsored by UConn Health. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-01.
Sponsored by UConn Health · Not applicable, Interventional, and Treatment
Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.
1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.
This study's enrollment of 120 is above the median of 87 across 1,371 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →UConn Health is the lead sponsor of 182 studies on the registry; 18 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Standard Care
Behavioral: Standard Care
Standard Care plus Prize Contingency Management for Alcohol Abstinence
Behavioral: Prize Contingency Management for Alcohol Abstinence · Behavioral: Standard Care
The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors
longest duration of abstinence from alcohol
objective report of alcohol use as measured by SCRAMx device
Time frame: three months
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
UConn Health